Yelena Ginzburg

19/03/24

1 item of Media coverage

Press/Media

Novel Treatment for Polycythemia Vera Shows Promise in Clinical Trial

Ginzburg, Y. & Hoffman, R.

11/03/24

1 item of Media coverage

Press/Media

Novel treatment for polycythemia vera shows promise in clinical trial

27/02/24

2 items of Media coverage

Press/Media

A "very promising" drug for polycythemia vera, the cancer suffered by Maite Galdeano, has been achieved.

Ginzburg, Y. & Hoffman, R.

22/02/24

1 item of Media coverage

Press/Media

News Drug Trial Shows Promise Treating Rare Blood Cancer A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debi

22/02/24

2 items of Media coverage

Press/Media

A Mount Sinai-Led Study Shows Early Success of a Novel Drug in Treating a Rare and Chronic Blood Cancer

22/02/24

1 item of Media coverage

Press/Media

A Mount Sinai-Led Study Shows Early Success of a Novel Drug in Treating a Rare and Chronic Blood Cancer

21/02/24

4 items of Media coverage

Press/Media

A Mount Sinai-Led Study Shows Early Success of a Novel Drug in Treating a Rare and Chronic Blood Cancer

21/02/24

1 item of Media coverage

Press/Media

Findings from Second Xiangya Hospital Update Understanding of Thalassemia (Single-cell Profiling of Ineffective Erythropoiesis In a Mouse Model of Beta-thalassaemia Intermedia)

11/04/23

1 item of Media coverage

Press/Media

Studies from Icahn School of Medicine at Mount Sinai Provide New Data on Polycythemia Vera (Hepcidin Mimetics In Polycythemia Vera: Resolving the Irony of Iron Deficiency and Erythrocytosis)

Hoffman, R., Ginzburg, Y. & Kremyanskaya, M.

29/03/23

1 item of Media coverage

Press/Media

Protagonist Therapeutics: More Good News Likely To Come

9/03/23

1 item of Media coverage

Press/Media

Protagonist Reports Second Quarter 2022 Financial Results and Provides Corporate Update

4/08/22

61 items of Media coverage

Press/Media

Von Willebrand factor A1 domain stability and affinity for GPIbα are differentially regulated by its O-glycosylated N- and C-linker

Ginzburg, Y. & Zaidi, M.

9/05/22

1 item of Media coverage

Press/Media

Discipline Spotlight: Publishing metabolism research at eLife

Buettner, C., Ginzburg, Y., Fisher,, E., Wassarman, P., Yuen, T. & Zaidi, M.

20/04/22

1 item of Media coverage

Press/Media

Aging is associated with increased brain iron through cortex-derived hepcidin expression

Ginzburg, Y. & Zaidi, M.

11/01/22

1 item of Media coverage

Press/Media

Rusfertide reduces hematocrit without phlebotomy in polycythemia vera

13/12/21

1 item of Media coverage

Press/Media

eLife Latest: Our expanded editorial team in medicine

Narla,, G., Buettner, C., Ginzburg, Y., Fisher,, E., Yuen, T. & Zaidi, M.

13/12/21

1 item of Media coverage

Press/Media

Protagonist Therapeutics (PTGX) Reports Updated Phase 2 Rusfertide Data in Polycythemia Vera (PV)

12/12/21 → 13/12/21

3 items of Media coverage

Press/Media

Protagonist Therapeutics Presents Updated Phase 2 Rusfertide Data in Polycythemia Vera (PV) at ASH 2021 Annual Meeting'

12/12/21

78 items of Media coverage

Press/Media

Protagonist Therapeutics Presents Updated Phase 2 Rusfertide Data in Polycythemia Vera (PV) at ASH 2021 Annual Meeting'

Ginzburg, Y. & Kremyanskaya, M.

12/12/21

1 item of Media coverage

Press/Media

Protagonist Therapeutics to Present Updated Clinical Data for Hepcidin Mimetic PTG-300 in Polycythemia Vera at the American Society for Hematology (ASH) 2020 Annual Meeting

4/11/20

14 items of Media coverage

Press/Media

MPN Research Foundation Announces 2019-2020 Grantees for MPN Challenge Grant program

28/09/19

1 item of Media coverage

Press/Media

MPN Research Foundation Announces 2019-2020 Grantees for MPN Challenge Grant program

25/09/19

1 item of Media coverage

Press/Media

MPN Research Foundation Announces 2019-2020 Grantees for MPN Challenge...